Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

A recent study has revealed a surprising connection between a seemingly harmless habit—nose picking—and the potential risk of ...

ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on developing precision therapies for neurodegenerative diseases, today announced the initiation of its Phase 1b ...

ProMIS Neurosciences (PMN) announced the initiation of its Phase 1b clinical trial evaluating its lead therapeutic candidate, PMN310, in ...

For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...

A study published in 2022 revealed a tenuous but plausible link between picking your nose and increasing the risk of ...

Among the FDA’s pending decisions for this quarter are Vertex’s non-opioid pain drug and Sanofi’s RNA interference therapy ...

Microglia can partially break down amyloid plaques by "spitting" a digestive enzyme at them, a new study has found.

Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...